Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Local Coverage Determination Clarification Act of 2016
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule; H.R.5721 - Local Coverage Determination Clarification Act of 2016 Medicare Clinical Laboratory Fee Schedule; Clinical Laboratory Improvement Amendments of 1988; Medical Devices (Diagnostic); Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Local Coverage Determination Clarification Act of 2016
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2026 · third_quarter · Q3
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services; immigration
Source: Senate LDA
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule; H.R.5721 - Local Coverage Determination Clarification Act of 2016 Medicare Clinical Laboratory Fee Schedule; Clinical Laboratory Improvement Amendments of 1988; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Records, Health Information Technology Reform Act (HR1309); Physician Quality Reporting System; Stark Self-Referral Act Reform; Medicare Physician and Clinical Laboratory Fee Schedules; Elimination of Medicare Sustainable Growth Rate; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative; Regulation of Laboratory Developed Tests
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Records, Health Information Technology Reform Act (HR1309); Physician Quality Reporting System; Stark Self-Referral Act Reform; Medicare Physician and Clinical Laboratory Fee Schedules; Elimination of Medicare Sustainable Growth Rate; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Records (H.R. 4066); Stark Self Referral Reform; H.R. 1309 Health Information Technology Reform Act; Elimination of SGR Formula Under Medicare; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Records (H.R. 1309); Health Information Technology Reform; Physician Self Referral Reform; Elimination of the Sustainable Growth Rate (Medicare); Graduate Medical Education; Allied Health Education; Appropriationns for Federal Health Agencies; Global Health.
To modify the efficiency standards for grid-enabled water heaters.
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Records (H.R. 4066); Stark Self Referral Reform; H.R. 1309 Health Information Technology Reform Act; Elimination of SGR Formula Under Medicare; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
Health Information Technology Reform Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Appropriations for Federal Health Agencies Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Clinical Lab Fee Schedule HR 6118 Essential Steps for Testing Act
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Appropriations for Federal Health Agencies Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Clinical Lab Fee Schedule HR 6118 Essential Steps for Testing Act
Resident Physician Shortage Reduction and Graduate Medical Education Accountability and Transparency Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
Resident Physician Shortage Reduction and Graduate Medical Education Accountability and Transparency Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Workforce Investment Act Reauthorization and Appropriations -- Career Pathways Innvoation Fund Health Care Reform Allied Health (Laboratory Professionals -- Workforce Shortage) HR 3962, the Affordable Health Care for America Act
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- Both Senate and House Versions Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Workforce Investment Act Reauthorization and Appropriations -- Career Pathways Innvoation Fund -- Appropriations Health Care Reform Allied Health (Laboratory Professionals -- Workforce Shortage); Appropriations HR 3962, the Affordable Health Care for America Act
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- Both Senate and House Versions Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- the Patient Protection and Affordable Care Act Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009 HR 3962, the Affordable Health Care for America Act Health Care Reform -- Senate and House Versions Elimination of SGR Formula Under Medicare
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare; HR 3962, the Affordable Health Care for America Act
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- the Patient Protection and Affordable Care Act Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts-- House Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriation
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare; HR 3962, the Affordable Health Care for America Act
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009 HR 3962, the Affordable Health Care for America Act Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
H.R. 1 American Recovery and Reinvestment Act of 2009 Health Care Reform -- Tri Committee Draft Proposal -- Various Senate Finance Committee Drafts -- HELP Committee Drafts Allied Health (Laboratory Professionals -- Workforce Shortage) HR 3962, the Affordable Health Care for America Act
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Cytology Proficiency Improvement Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
S.605 the Allied Health Reinvestment Act
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
S.605 the Allied Health Reinvestment Act
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
S.605 the Allied Health Reinvestment Act
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
S.605 the Allied Health Reinvestment Act
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Laboratory Test Improvement Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
Genomics and Personalized Medicine Act of 2007
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
Cytology Proficiency Improvement Act of 2008
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; immigration issues impacting laboratory workforce
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), SENATE, U.S. Immigration & Customs Enforcement (ICE), Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2026 · second_quarter · Q2
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; immigration issues impacting laboratory workforce
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services; immigration
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Employment & Training Administration, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2026 · first_quarter · Q1
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services; immigration
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; immigration issues impacting laboratory workforce
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Employment & Training Administration, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2025 · fourth_quarter · Q4
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services; immigration
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; immigration issues impacting laboratory workforce
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2025 · third_quarter · Q3
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; immigration issues impacting laboratory workforce
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2025 · second_quarter · Q2
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2025 · second_quarter · Q2
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2025 · first_quarter · Q1
Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2024 · fourth_quarter · Q4
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2024 · third_quarter · Q3
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2024 · second_quarter · Q2
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2024 · first_quarter · Q1
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2023 · fourth_quarter · Q4
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2023 · third_quarter · Q3
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2023 · second_quarter · Q2
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2023 · first_quarter · Q1
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness.
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2022 · fourth_quarter · Q4
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2022 · third_quarter · Q3
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness.
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2022 · second_quarter · Q2
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2022 · first_quarter · Q1
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness,
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2021 · fourth_quarter · Q4
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness,
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2021 · third_quarter · Q3
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness,
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2021 · second_quarter · Q2
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness,
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2021 · first_quarter · Q1
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2020 · fourth_quarter · Q4
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments, Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2020 · third_quarter · Q3
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations/Authorizations for Federal Health Agencies and programs, such as Title VII; Global Health Initiative (PEPFAR); issues related to COVID-19 response and laboratory test capacity.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments, Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2020 · second_quarter · Q2
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations/Authorizations for Federal Health Agencies and programs, such as Title VII; Global Health Initiative (PEPFAR); issues related to COVID-19 response and laboratory test capacity.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2020 · first_quarter · Q1
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments, Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2019 · fourth_quarter · Q4
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations/Authorizations for Federal Health Agencies and programs, such as Title VII; Global Health Initiative (PEPFAR).
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2019 · third_quarter · Q3
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations/Authorizations for Federal Health Agencies and programs, such as Title VII; Global Health Initiative (PEPFAR).
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2019 · second_quarter · Q2
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2019 · first_quarter · Q1
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2018 · fourth_quarter · Q4
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2018 · third_quarter · Q3
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2018 · second_quarter · Q2
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2018 · first_quarter · Q1
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2017 · fourth_quarter · Q4
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2017 · third_quarter · Q3
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2017 · second_quarter · Q2
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Appropriations for Federal Health Agencies; Global Health Initiative;
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2017 · first_quarter · Q1
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2016 · fourth_quarter · Q4
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule; H.R.5721 - Local Coverage Determination Clarification Act of 2016 Medicare Clinical Laboratory Fee Schedule; Clinical Laboratory Improvement Amendments of 1988; Medical Devices (Diagnostic); Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2016 · third_quarter · Q3
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule; H.R.5721 - Local Coverage Determination Clarification Act of 2016 Medicare Clinical Laboratory Fee Schedule; Clinical Laboratory Improvement Amendments of 1988; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; on-Communicable Disease
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2016 · second_quarter · Q2
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; on-Communicable Disease
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Medicare Access and CHIP Reauthorization Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Protecting Access to Medicare Act; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2016 · first_quarter · Q1
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2015 · fourth_quarter · Q4
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2015 · third_quarter · Q3
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2015 · second_quarter · Q2
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2015 · first_quarter · Q1
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2014 · fourth_quarter · Q4
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiatives
Physician Workforce Shortages and Graduate Medical Education; Laboratory Personnel Workforce Shortages and Allied Health Education; Reauthorization of Workforce investment Act; Appropriations for Federal Health Agencies
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2014 · third_quarter · Q3
Implementation of Affordable Care Act; Electronic Health Records, Health Information Technology Reform Act (HR1309); Physician Quality Reporting System; Stark Self-Referral Act Reform; Medicare Physician and Clinical Laboratory Fee Schedules; Elimination of Medicare Sustainable Growth Rate; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative
Laboratory Workforce Shortage and Personnel Issues; REauthoriztion of Workforce Investment Act; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2014 · second_quarter · Q2
Affordable Care Act Implementation; Electronic Health Records; Physician Quality Reporting System; Stark Self Referral Reform; Medicare Sustainable Growth Rate; Medicare Physician Fee Schedule; Medicare Clinical Laboratory Fee Schedule; Medicare; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages, Appropriations for Federal Health Agencies; Global Health Initiatives
Affordable Care Act Implementation; Medicare; Electronic Health Records; Physician Quality Reporting System; Stark Self Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages, Appropriations for Federal Health Agencies; Global Health Initiatives
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2014 · first_quarter · Q1
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies (HRSA and DOL).
Affordable Care Act Implementation; Medicare: Physician and Clinical Laboratory Fee Schedules; Electronic Health Records/Health Information Technology (HIT Reform Act); Physician Quality Reporting System; Stark Self Referral Reform; Regulation of Laboratory Developed Tests; Elimination of Sustainable Growth Rate (Medicare); Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiatives;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2013 · fourth_quarter · Q4
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies (HRSA and DOL).
Implementation of Affordable Care Act; Medicare: Physician and Clinical Laboratory Fee Schedules; Electronic Health Records; Health Information Technology Reform Act; Physicain Quality Reporting System; Stark Self Referral Reform; Elimination of Sustainable Growth Rate (Medicare); Regulation of Laboratory Developed Tests; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Insurance
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2013 · third_quarter · Q3
Laboratory Workforce Shortage; Reauthorizations of Workforce Investment Act; Appropriations for HRSA; Appropriations for DOL
Affordable Care Act; Electronic Health Records/Health Information Technology Incentive Program; Stark Self Referral Reform; Elimination of Sustainable Growth Rate Formula; Graduate Medical Education; Allied Heatlh Education; Appropriations for Federal Health Agencies; Global Health Initiative
Appropriations for Federal Health Agencies; Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortages; Graduate Medical Education, Regulation of Laboratory Developed Tests; Clinical Laboratory Fee Schedule & Physician Fee Schedule
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2013 · second_quarter · Q2
Implementation of Affordable Care Act; Electronic Health Records (H.R. 1309); Health Information Technology Reform; Physician Self Referral Reform; Elimination of the Sustainable Growth Rate (Medicare); Graduate Medical Education; Allied Health Education; Appropriationns for Federal Health Agencies; Global Health.
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Acty; Appropriations for HRSA; Appropriations for DOL
Appropriationns for Federal Health Agencies; Physician Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortages; Graduate Medical Education; Regulation of Laboratory Developed Tests; Medicare: Clinical Laboratory and Physician Fee Schedules;
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2013 · first_quarter · Q1
Laboratory Workforce Shortage; Reauthorization of Workforce investment Act; Appropriations for HRSA; Appropriations for DOL
Appropriations for Federal Health Agencies; Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortages; Graduate Medical Education; Regualtion of Laboratory Developed Tests; Medicare: Clinical Laboratory Fee Schedule & Physician Fee Schedule
Implementation of Affordable Care Act; Electronic Health Records (H.R. 4066); Stark Self Referral Reform; H.R. 1309 Health Information Technology Reform Act; Elimination of SGR Formula Under Medicare; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2012 · fourth_quarter · Q4
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA;Appropriations for the DOL
Appropriations for Federal Health Agencies Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Clinical Lab Fee Schedule HR 6118 Essential Steps for Testing Act
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2012 · third_quarter · Q3
Appropriations for Federal Health Agencies Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Clinical Lab Fee Schedule HR 6118 Essential Steps for Testing Act
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform; HR 6118 Essential Steps for Testing Act Elimination of SGR Formula Under Medicare; HR 6352 Physician Shortage Reduction & GME Accountability Act Appropriations for Federal Health Agencies; Global Health Initiative
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2012 · second_quarter · Q2
Appropriations for Federal Health Agencies Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Clinical Lab Fee Schedule
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA;Appropriations for the DOL
Implementation of Affordable Care Act; Electronic Health Record (H.R.4066) Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2012 · first_quarter · Q1
Implementation of Affordable Care Act; Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
Appropriations for Federal Health Agencies Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Clinical Lab Fee Schedule
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA;Appropriations for the DOL
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2011 · fourth_quarter · Q4
Implementation of Affordable Care Act; Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
Appropriations for Federal Health Agencies Stark Self Referral Reform; Elimination of SGR; Workforce Investment Act -- Laboratory Workforce Shortage Regulation of Laboratory Developed Tests; Debt Ceiling Negotiations
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2011 · third_quarter · Q3
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA
Appropriations for Federal Health Agencies; Deficit Reduction Elimination of Physician Signature Requirement Under Medicare PFS Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortag Regulation of Laboratory Developed Tests; Debt Ceiling Negotiations
Implementation of Affordable Care Act; Deficit Reduction Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2011 · second_quarter · Q2
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA
Appropriations for Federal Health Agencies Elimination of Physician Signature Requirement Under Medicare PFS Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortag Regulation of Laboratory Developed Tests; Debt Ceiling Negotiations
Implementation of Affordable Care Act; Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2011 · first_quarter · Q1
Implementation of Affordable Care Act; Stark Self-Referral Reform Elimination of SGR Formula Under Medicare Appropriations for Federal Health Agencies; Global Health Initiative
Appropriations for Federal Health Agencies Elimination of Physician Signature Requirement Under Medicare PFS Stark Self Referral Reform Laboratory Workforce Shortage; Regulation of Laboratory Developed Tests
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2010 · fourth_quarter · Q4
Workforce Investment Act Reauthorization and Appropriations -- Career Pathways Innvoation Fund Health Care Reform -- the Patient Protection and Affordable Care Act Allied Health (Laboratory Professionals -- Workforce Shortage), Title VII Appropriations for Allied Health
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- the Patient Protection and Affordable Care Act Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2010 · third_quarter · Q3
Workforce Investment Act Reauthorization and Appropriations -- Career Pathways Innvoation Fund Health Care Reform -- the Patient Protection and Affordable Care Act Allied Health (Laboratory Professionals -- Workforce Shortage), Title VII Appropriations for Allied Health
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- the Patient Protection and Affordable Care Act Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2010 · second_quarter · Q2
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- Both Senate and House Versions Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
Workforce Investment Act Reauthorization and Appropriations -- Career Pathways Innvoation Fund -- Appropriations Health Care Reform Allied Health (Laboratory Professionals -- Workforce Shortage); Appropriations HR 3962, the Affordable Health Care for America Act
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2010 · first_quarter · Q1
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- Both Senate and House Versions Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
H.R. 1 American Recovery and Reinvestment Act of 2009 HR 3962, the Affordable Health Care for America Act Health Care Reform -- Senate and House Versions Elimination of SGR Formula Under Medicare
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2009 · fourth_quarter · Q4
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare; HR 3962, the Affordable Health Care for America Act
H.R. 1 American Recovery and Reinvestment Act of 2009 HR 3962, the Affordable Health Care for America Act Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2009 · third_quarter · Q3
H.R. 1 American Recovery and Reinvestment Act of 2009 Health Care Reform -- Tri Committee Draft Proposal -- Various Senate Finance Committee Drafts -- HELP Committee Drafts Allied Health (Laboratory Professionals -- Workforce Shortage)
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriations
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2009 · second_quarter · Q2
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2009 · first_quarter · Q1
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Cytology PT Allied Health (Laboratory Professionals -- Workforce Shortage)
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform Allied Health (Laboratory Professionals -- Workforce Shortage)
H.R. 1 American Recovery and Reinvestment Act of 2009 Allied Health (Laboratory Professionals -- Workforce Shortage)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2008 · fourth_quarter · Q4
S.605 the Allied Health Reinvestment Act
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2008 · third_quarter · Q3
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
S.605 the Allied Health Reinvestment Act
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2008 · second_quarter · Q2
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2008 · first_quarter · Q1
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2007 · year_end · YY
S 605 the Allied Health Reinvestment Act
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; S 605 the Allied Health Reinvestment Act, HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2007 · mid_year · MM
* HR 3162, Cytology Proficency Testing Regulations, CPT coding, Physician Self-Referral Provisions, Competetive Bidding Demo Project on Clinincal Lab Services HR 1237, Physician Self-Referral Regulations (Physican Fee Schedule), Competetive Bidding Demo Project on Clinincal Lab Services
S 605
HR 3162, HR 1237, S976, S736, S605
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2006 · year_end · YY
HR 3010, HR 1775, S.473/HR215, S1873
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
HR 2356, S 1081, HR 2218
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness.
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Loan Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues, including OPM position classifications/descriptions; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity;
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Medicare & Affordable Care Act; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
Affordable Care Act, Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness,
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations/Authorizations for Federal Health Agencies and programs, such as Title VII; Global Health Initiative (PEPFAR); issues related to COVID-19 response and laboratory test capacity.
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments, Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and descriptions; Clinical Laboratory Improvement Amendments; Appropriations/Authorizations for Federal Health Agencies and programs, such as Title VII; Global Health Initiative (PEPFAR); issues related to COVID-19 response and laboratory test capacity.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments, Laboratory Access for Beneficiaries (LAB) Act.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Clinical Laboratory Improvement Amendments; Appropriations for Federal Health Agencies; Global Health Initiative;
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Clinical Laboratory Improvement Amendments.
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician Shortages and Graduate Medical Education; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases
Physician and Allied Health Shortages and Education; Workforce Reinvestment Act; Federal Healthcare Workforce issues, including OPM job classifications and description; Appropriations for Federal Health Agencies; Global Health Initiative;
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Medicare Access and CHIP Reauthorization Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Protecting Access to Medicare Act; Physician Shortages and Graduate Medical Education; Clinical Laboratory Improvement Amendments of 1988; Medical Devices, Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Clinical Laboratory Improvement Amendments of 1988; Physician Shortages and Graduate Medical Education; on-Communicable Disease
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Medicare Access and CHIP Reauthorization Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Protecting Access to Medicare Act; Physician Shortages and Graduate Medical Education; Clinical Laboratory Improvement Amendments of 1988; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Workforce Reinvestment Act; Appropriations for Federal Agencies; Global Health Initiatives
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
Affordable Care Act Implementation; Medicare; Physician and Clinical Laboratory Fee Schedules; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Regulation of Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiatives
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Implementation of Affordable Care Act; Electronic Health Records, Health Information Technology Reform Act (HR1309); Physician Quality Reporting System; Stark Self-Referral Act Reform; Medicare Physician and Clinical Laboratory Fee Schedules; Elimination of Medicare Sustainable Growth Rate; Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative; Regulation of Laboratory Developed Tests
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA)
Laboratory Workforce Shortages; Workforce Investment Act; Appropriations for HRSA; Appropriations for DOL; Physician Workfoce/Graduate Medical Education; Global Health Initiatives
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
Affordable Care Act Implementation; Electronic Health Records/Health Information Technology; Physician Quality Reporting System; Stark Self Referral Reform; Elimination of Sustainable Growth Rate (Medicare); Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiatives;
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)
Implementation of Affordable Care Act; Electronic Health Records; Health Information Technology Reform Act; Physicain Quality Reporting System; Stark Self Referral Refrom; Elimination of Sustainable Growth Rate (Medicare); Graduate Medical Education; Allied Health Education; Appropriations for Federal Health Agencies; Global Health Initiative
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Laboratory Workforce Shortage; Reauthorization of Workforce Investment Act; Appropriations for HRSA;Appropriations for the DOL
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
Filing targets: Bureau of Labor Statistics (BLS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Regulation of Laboratory Developed Tests and Direct to Consumer Tests Health Care Reform -- the Patient Protection and Affordable Care Act Elimination of SGR Formula Under Medicare
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Regulation of Laboratory Developed Tests Health Care Reform -- the Patient Protection and Affordable Care Act Elimination of SGR Formula Under Medicare
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare; HR 3962, the Affordable Health Care for America Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Workforce Investment Act Reauthorization and Appropriations -- Career Pathways Innvoation Fund Health Care Reform Allied Health (Laboratory Professionals -- Workforce Shortage) HR 3962, the Affordable Health Care for America Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
H.R. 1 American Recovery and Reinvestment Act of 2009 Health Care Reform -- Tri Committee Draft Proposal -- Various Senate Finance Committee Drafts -- HELP Committee Drafts Allied Health (Laboratory Professionals -- Workforce Shortage) HR 3962, the Affordable Health Care for America Act
H.R. 1 American Recovery and Reinvestment Act of 2009; HR 3962, the Affordable Health Care for America Act; Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts-- House Allied Health (Laboratory Professionals -- Workforce Shortage) -- Elimination of SGR Formula Under Medicare Appropriation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE
H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE
H.R. 1 American Recovery and Reinvestment Act of 2009 Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Allied Health (Laboratory Professionals -- Workforce Shortage)
H.R. 1 American Recovery and Reinvestment Act of 2009 Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.605 the Allied Health Reinvestment Act
HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007; MUE; SGR Reform; anti mark-up regulatory reform; HR 6331, the Medicare Improvement for Patients and Providers Act of 2008; Stark Related Provisions in Medicare
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.605 the Allied Health Reinvestment Act
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 3162,Children's Health and Medicare Protection Act of 2007; S 976 Genomics and Personalized Medicine Act of 2007; S. 736 Laboratory Test Improvement Act ; , HR 1237 and S. 2510 Cytology Proficiency Improvement Act of 2007;S. 2099 Preserving Access to Laboratory Services Act of 2007; CPT Coding; Physician Self-Referral Provisions; HR 3453, Community Clinical Laboratory Fairness in Competition Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare Lab Services Competetive Bidding Demo Project, CPT Coding, MUE Issues, Physician Self Referral Regulations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR3010, HR 1175, S.473/HR 215, HR 2356
HR 3010, HR 1775, S.473/HR215, S1873
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE